Aardvark Therapeutics logo

Aardvark Therapeutics Share Price Today (NASDAQ: AARD)

Aardvark Therapeutics share price is $10.72 & ₹922.62 as on 15 Jun 2025, 2.30 'hrs' IST

$10.72

-0.34

(-3.07%)

Market is closed - opens 7 PM, 16 Jun 2025

View live Aardvark Therapeutics share price in Dollar and Rupees. Guide to invest in Aardvark Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Aardvark Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Aardvark Therapeutics (AARD) Key Statistics

in dollars & INR

Previous Close
$11.06
Open
$11.0
Market Capitalization
$284.4M
Today's Volume
$14.3K
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-0.65
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

How to invest in Aardvark Therapeutics Stock (AARD) from India?

It is very easy for Indian residents to invest directly in Aardvark Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aardvark Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aardvark Therapeutics or AARD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aardvark Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aardvark Therapeutics shares which would translate to 0.080 fractional shares of Aardvark Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Aardvark Therapeutics, in just a few clicks!

Returns in Aardvark Therapeutics (AARD) for Indian investors in Rupees

The Aardvark Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aardvark Therapeutics investment value today

Current value as on today

₹77,951

Returns

₹22,049

(-22.05%)

Returns from Aardvark Therapeutics Stock

₹25,087 (-25.09%)

Dollar Returns*

₹3,039 (+3.04%)

Indian investors sentiment towards Aardvark Therapeutics (AARD)

-56%

Period: May 15, 2025 to Jun 14, 2025. Change in 30 Days versus previous period

Search interest for Aardvark Therapeutics Stock from India on INDmoney has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Aardvark Therapeutics

Rating
Trend

Insights on Aardvark Therapeutics Stock (Ticker Symbol: AARD)

  • Price Movement

    In the last 1 month, AARD stock has moved up by 26.5%

Aardvark Therapeutics Technicals Summary

Sell

Neutral

Buy

Aardvark Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Aardvark Therapeutics (AARD) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Aardvark Therapeutics logo
11.83%
-22.71%
-22.71%
-22.71%
-22.71%
Regeneron Pharmaceuticals, Inc. logo
-11.02%
-27.05%
-49.42%
-5.02%
-10.81%
Beone Medicines Ltd logo
18.08%
52.93%
69.2%
101.57%
55.67%
Vertex Pharmaceuticals Incorporated logo
3.86%
-2.68%
-3.83%
81.53%
66.4%
Alnylam Pharmaceuticals, Inc. logo
7.76%
26.01%
95.45%
128.04%
132.45%

About Aardvark Therapeutics

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Its lead product candidate is ARD-101, an oral gut-restricted small-molecule agonist of certain targeting bitter taste receptors expressed in the gut lumen, which is in the Phase 3 clinical trial for hyperphagia associated with Prader-Willi Syndrome, as well as in the Phase 2 clinical trial for hyperphagia associated with acquired hypothalamic obesity resultant from the treatment of craniopharyngioma, including surgery or radiation. The company is also developing ARD-201, which is in the Phase 1 clinical trial for the treatment of obesity. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
Organization
Aardvark Therapeutics
Employees
26
CEO
Dr. Tien-Li Lee M.D.
Industry
Miscellaneous

Management People of Aardvark Therapeutics

NameTitle
Dr. Tien-Li Lee M.D.
CEO, Secretary & Director
Dr. Bryan Jones Ph.D.
Chief Operating Officer
Dr. Manasi Sinha Jaiman M.D., M.P.H.
Chief Medical Officer
Mr. Nelson B. Sun M.B.A.
Chief Financial Officer
Dr. Timothy J. Kieffer Ph.D.
Chief Scientific Officer
Mr. Christian Zapf J.D.
General Counsel
Dr. Dvorit Samid Ph.D.
Executive Vice President of Medical Affairs
Dr. Zhenhuan Zheng Ph.D.
Chief Research Officer
Mr. Ron Lewis II, Ph.D.
VP & Head of CMC
Dr. Terrie Kellmeyer Ph.D.
Senior Vice President of Regulatory Affairs

Important FAQs about investing in AARD Stock from India :

Can Indians buy Aardvark Therapeutics shares?

Yes, Indians can invest in the Aardvark Therapeutics (AARD) from India.

With INDmoney, you can buy Aardvark Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Aardvark Therapeutics at zero transaction cost.

How can I buy Aardvark Therapeutics shares from India?

It is very easy to buy Aardvark Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aardvark Therapeutics (AARD) be purchased?

Yes, you can buy fractional shares of Aardvark Therapeutics with INDmoney app.

What are the documents required to start investing in Aardvark Therapeutics stocks?

To start investing in Aardvark Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Aardvark Therapeutics share price today?

Aardvark Therapeutics share price today stands at $10.72, Open: $11.00 ; Previous Close: $11.06 ; High: {{1_rba_end}} ; Low: {{1_rba_st}} ; 52 Week High: {{rba_end}} ; 52 Week Low: {{rba_st}}.

The stock opens at $11.00, after a closing price of $11.06. The stock reached a daily high of {{1_rba_end}} and a low of {{1_rba_st}}, with a 52-week high of {{rba_end}} and a 52-week low of {{rba_st}}.

What are today’s High and Low prices of Aardvark Therapeutics Stock (AARD)?

Today’s highest price of Aardvark Therapeutics (AARD) is {{1_rba_end}}.

Today’s lowest price of Aardvark Therapeutics (AARD) is {{1_rba_st}}.

What is the 52 Week High and Low Range of Aardvark Therapeutics Stock (AARD)?

  • 52 Week High

    {{rba_end}}

  • 52 Week Low

    {{rba_st}}

What are the historical returns of Aardvark Therapeutics (AARD)?

  • 1 Month Returns

    11.83%

  • 3 Months Returns

    -22.71%

  • 1 Year Returns

    -22.71%

  • 5 Years Returns

    -22.71%

What is today's market capitalisation of Aardvark Therapeutics?

Today's market capitalisation of Aardvark Therapeutics AARD is 284.4M

Who is the Chief Executive Officer (CEO) of Aardvark Therapeutics ?

Dr. Tien-Li Lee M.D. is the current Chief Executive Officer (CEO) of Aardvark Therapeutics.